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Background: The effect of transport temperature on the viability of poliovirus in stool specimens from
paralyzed cases has not been tested. Quality assurance of programmatic indicators will be necessary in
the ﬁnal phase of polio eradication.
Objective: To estimate the effect of time at elevated temperatures on wild poliovirus titers in stool
specimens.
Methods: We exposed aliquots of pooled wild poliovirus type 1 specimens to elevated temperatures
(27 1C, 31 1C, and 35 1C) for varying time periods up to 14 days. We determined the virus titer of these
aliquots and created decay curves at each temperature to estimate the relationship between time at
temperature and virus titer.
Results: We found signiﬁcantly different slopes of decay at each temperature. The negative slopes
increased as the temperature increased.
Conclusions: While poliovirus in stool remains relatively stable at moderately elevated temperature,
transport at higher temperatures could impact sample integrity and virus isolation results.
Published by Elsevier Inc.
Introduction
The Global Polio Eradication Initiative (GPEI) is a remarkable
public health and scientiﬁc venture. Success with poliovirus will
make it the second human pathogen, after smallpox, to be
eradicated from the natural world. To achieve the goal of eradicat-
ing all 3 wild polioviruses (WPV), the program relies on surveil-
lance, leading to the timely investigation of infants, children and
other persons with a clinical syndrome of acute ﬂaccid paralysis
(AFP). AFP surveillance entails the detection of any case of AFP in a
child under 15 years and any case of any age where the physician
suspects polio (WHO, 1996). AFP surveillance systems in endemic
regions are expected to identify at least two non-polio AFP cases
per 100,000 population aged o15 years to demonstrate capacity
for detecting poliovirus transmission should it be occurring (WHO,
1996). High quality surveillance combines timely identiﬁcation,
and prompt and complete investigation of suspected AFP cases.
Proper investigation includes collection of two adequate stool
specimens from each AFP case at least 24 h apart, within 14 days
of onset of paralysis. Alongside identiﬁcation of suspect cases, the
appropriate collection, handling and shipment of stool specimens
to a global network of laboratories that are capable of performing
virus isolation, typing and intratypic differentiation, using both
classical virological and molecular techniques is vital to the
eradication effort. The success of the program depends on sensi-
tive and timely ﬁeld investigations and accurate diagnostic testing
by the laboratories. A fundamental attribute of the GPEI has been
the standardization of laboratory and ﬁeld procedures to achieve
the goal virus eradication. To ensure validity of the laboratory
testing that will document the successful eradication of poliovirus,
stool specimens should be transported to a WHO-accredited
laboratory within 72 h after collection in a “reverse cold chain”,
maintaining a temperature o8 1C, and without leakage or desic-
cation (WHO, 1989). Laboratory activities to identify and charac-
terize poliovirus depend on the execution of the standardized ﬁeld
implementation of the reverse cold chain.
WPV in solution has been shown to be temperature-sensitive in
virus inactivation studies during vaccine development stability
testing (Melnick, 1991), but the temperature standard speciﬁed for
stools during transport is based on studies of oral poliovirus
vaccine viability in solution. Oral poliovirus vaccine is the most
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heat-sensitive vaccine in use; the vaccine can be stored at 2–8 1C
for a maximum of 6 months to maintain potency (WHO, 1989).
Serotype 1 is the most temperature-sensitive of the three polio-
virus serotypes in solution. The recommended temperature range
is based on data from multiple studies deﬁning time- and
temperature-dependent titer loss, including a 0.3 log10 titer loss
after storage at 4 1C for 18 months (WHO, 1990; Sokhey et al.,
1988; Peetermans and C.G., 1980; World Health Organization Polio
Laboratory Manual, 2004; Wood and Hull, 1999; Finney, 1978).
Exposure to higher temperatures increased the rate of decay for
stabilized vaccine; oral polio vaccine titers declined 20% when
stored at 22 1C for 14 days, and 50% when stored at 36 1C for 14
days; Storage at 36 1C for three weeks resulted in nearly complete
titer loss (Sokhey et al., 1988). No studies characterizing the heat
sensitivity of wild or vaccine poliovirus in specimens have been
published.
AFP cases are classiﬁed as polio cases based on the results of
poliovirus isolation; characterization as “non-polio“ following a
negative results assumes proper collection, storage and shipment
to an accredited laboratory, i.e., an intact reverse cold chain.
However, little is known about how transport conditions would
affect the detection of WPV in stool specimens. Anecdotally,
temperatures in transit frequently vary outside the recommended
range, especially in tropical and semi-arid regions where polio
remains endemic. We undertook this study to estimate the effect
of time at elevated temperatures on WPV titers in stool specimens.
Objective
The objective of this study was to estimate the effect of time at
elevated temperatures on wild poliovirus titers in stool specimens
and describe the slope of decay of type 1 poliovirus when exposed
to different elevated temperatures.
Methods
RD (human rhabdomyosarcoma) and L20B (mouse L cell
engineered to express the human poliovirus receptor (Wood and
Hull, 1999)) were maintained in a 5% CO2 atmosphere at 37 1C in
minimal essential medium with Earle's salts (MEM; Invitrogen,
Carlsbad, CA), supplemented with 10% fetal bovine serum (FBS;
Atlas Biologicals, Fort Collins, CO, or Thermo Scientiﬁc,
Lafayette, CO).
A pilot experiment was performed to establish the appropriate
range of temperatures and incubation times to be tested in the
main study. Approximately 400 mL from each of ﬁve previously
characterized stool specimens, containing wild poliovirus type 1
(WPV1) detected by the standard WHO virologic surveillance
protocol (World Health Organization Polio Laboratory Manual,
2004), were pooled, mixed thoroughly, and divided into aliquots
of 50 mL in 23 individual 0.65 mL polypropylene microcentrifuge
tubes. Two aliquots were placed at 4 1C and seven aliquots were
placed in heat blocks at each of three temperatures, 25 1C, 35 1C,
and 45 1C. One aliquot was removed from each heat block at
approximately the same time each day on days 4, 8, 12, 16, 20, 24,
and 28, and stored at 4 1C until further analysis. Stool suspensions
(10% w/v) were made from each of the aliquots using standard
protocols (World Health Organization Polio Laboratory Manual,
2004). Ten-fold serial dilutions were prepared for each suspension
and each dilution was inoculated in duplicate onto monolayers of
RD cells in 24-well plates in MEM-2% FBS.
For the main experiment, we calculated power using the non-
central F density: 1β¼ prðF4FcritÞ, where Fcrit is the critical
value of the central F distribution for 1 and υ2 degrees of freedom
and a signiﬁcance of 0.05 (43). Assuming a moderate temperature
effect on WPV decay in specimens (range of slope decay of 0.1 to
0.4), lower correlation among the observations (0.5) and larger
standard deviation (0.75), we found that n¼8 different pools of
homogenized stool aliquoted and exposed to elevated tempera-
tures will result in a 1β¼0.91 for determination of the slope of
the decay curves. Ten pools of stool were created, each comprised
of six different poliovirus type 1-positive stools. Stools were
selected non-systematically from a library of WPV-positive speci-
mens at CDC. Approximately 250 mL of each of six stools were
pooled, mixed thoroughly and divided into 50 mL aliquots as above.
The baseline titer of each stool pool was determined by titration in
L20B cells (L20B cells are selective for poliovirus and are used to
reduce background CPE due to non-polio enteroviruses that might
be in the original stools (Wood and Hull, 1999)). One aliquot from
each pool was placed immediately at 4 1C and seven aliquots were
placed in each of three heat blocks at 27 1C, 31 1C, and 35 1C. An
aliquot was removed from each heat block at approximately the
same time each day on days 2, 4, 6, 8, 10, 12, and 14, and stored at
4 1C. Stool suspensions were made as described above. Ten-fold
serial dilutions were prepared and 10 replicates of each dilution
were inoculated onto L20B cells in 96-well plates. At ﬁve days
post-inoculation, plates were stained with crystal violet solution
(0.05% crystal violet, 0.5% Tween-20, 50% ethanol), washed three
times with deionized water, and allowed to dry overnight. Inocu-
lated cultures were maintained in a 5% CO2 atmosphere at 37 1C in
both the pilot and main experiment and were observed daily for
ﬁve days for development of cytopathic effect (CPE), an indicator
of the presence of intact poliovirus. For each incubated aliq-
uot, WPV1 titer (50% cell culture infectious dose (CCID50) per
gram stool) was calculated using the Spearman-Kärber formula
(Finney, 1978).
For both the pilot and main experiments, reverse transcription-
semi-nested polymerase chain reaction (RT-snPCR) and sequen-
cing (Nix et al., 2006) were used to determine whether viral
nucleic acid was detectable in stools that were negative in cell
culture at days 4, 8, 12, 16, 20, 24 and 28 for the pilot and days 1, 2,
3, 4, 7, 10 and 14 for the main experiment.
We analyzed the WPV1 isolation and titer results to determine
the difference in the loss of titer by temperature and time at
temperature, examining the slope of the decay curve at each
temperature using least squares regression. We did not assume
that data points below the titration assay's limit of detection (102
CCID50 per gram) equaled 0, and therefore excluded them from the
analysis to prevent biased estimates of the slopes. WPV1 titers
were analyzed using a generalized linear model with a repeated
measures ANOVA design using SAS software, version 9.1 (SAS
Institute Inc., Cary, NC). The measured dependent variable was the
slope of the log10 (titer) of WPV1 remaining vs. time, calculated for
each pool at each temperature. The independent variable was
temperature. Non-detection of WPV1 in the aliquot by cell culture
indicated the time endpoint for each temperature.
Results
In the pilot experiment, WPV1 was highly stable at 25 1C for at
least 28 days, with only minimal loss from 106 to 105 CCID50/g
(Fig. 1). WPV1 was stable at 35 1C for four days but rapidly lost titer
thereafter, losing 3 logs at 12 days and becoming undetectable by
16 days. After incubation at 45 1C, WPV1 was undetectable at
4 days, the earliest time point tested.
For the main experiment, the median baseline titer of the stool
pools was 104.66 CCID50/g with a range of 102.9–106 CCID50/g. Plots
of WPV1 decay curves by temperature showed an increased rate of
titer loss at higher temperatures (Fig. 2). We estimated the mean
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slope of WPV decay at 27 1C, 31 1C and 35 1C (Table 1). The three
mean temperature decay slopes were signiﬁcantly different from
each other (po0.01) (Table 1). The mean time to negative cell
culture results was eight days at 35 1C for high titer (4105.5
CCID50/g) specimens. Specimens with a low WPV titer at baseline
(o103.5 CCID50/g) reached the point of non-detection in a mean of
ﬁve days at 35 1C.
Negative aliquots from both experiments were tested using RT-
snPCR to determine the detectability of WPV after heat inactiva-
tion. Poliovirus was detectable by RT-snPCR and typeable by
sequencing the PCR amplicon in the pilot study samples exposed
at 25 1C or 35 1C for up to 28 days, and to 45 1C for up to 8 days,
even though virus was no longer detectable in culture after day
8 at 35 1C or after day 0 at 45 1C (Fig. 3A). In the main study
samples, WPV was detectable and typeable up to 14 days (the
longest incubation tested) at 27 1C, 31 1C, and 35 1C (Fig. 3B).
Discussion
The partners in the GPEI have developed quality control guide-
lines to assure vaccine effectiveness, including monitoring of the
“forward” cold chain with vaccine vial monitors. Guidelines for
transport of stool specimens are in place to assure stool integrity
and the ability of laboratories to isolate poliovirus in the specimen
if it is present (WHO, 1989). These quality assurance guidelines of
the “reverse” cold chain assume the potential negative effect of
adverse specimen transport (not arriving under proper cold
conditions) on the laboratory result; however, the conditions of
Fig. 1. Change in wild poliovirus type 1 titers in stool pools incubated for 4–28 days
at 25 1C, 35 1C, and 45 1C.
Fig. 2. Change in wild poliovirus titers in 10 stool pools incubated for 0–14 days at 27 1C, 31 1C, and 35 1C.
Table 1
Mean WPV decay slopes.
Temperature (1C) Mean slope Standard error Standard deviation
27 0.0855 0.01340 0.04591
31 0.1411 0.03844 0.13805
35 0.2581 0.04017 0.13446
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Fig. 3. Detection of wild poliovirus type 1 (WPV1) by reverse transcription-semi-
nested polymerase chain reaction in stool incubated at to elevated temperatures
over time. (A). WPV1-containing stool exposed for 4–28 days at 35 1C or 45 1C, and
for 28 days at 25 1C. (B). WPV1-containing stool exposed for 1–14 days at 31 1C or
35 1C, and for 14 days at 27 1C.
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specimens are not monitored during transport. In this study,
estimating the slopes of decay over time for WPV type 1 at
multiple temperatures common in arid and semi-arid locations
where poliovirus has or continues to circulate allowed more
accurate assessment of the risk of missing circulating virus (falsely
negative laboratory results) due to an inadequate reverse cold
chain. Increasing temperature will increase the rate of WPV titer
decay as will the amount of time a specimen is exposed to a given
temperature. The data presented underline the effect of high
temperature on virus decay and emphasize the need to prevent
specimen exposure to high ambient temperatures. However, this
study shows that under moderate heat stress, poliovirus titer
decreases are moderate even with extended exposure times. In
extreme conditions, with limitations in timely transport of speci-
mens, monitoring of temperatures inside specimen carriers may
be necessary to ascertain possible titer loss over time and the
potential impact on the quality of results reported to the GPEI.
Field observations have indicated that the emphasis placed on
the forward cold chain has not been placed on the reverse cold
chain. However, our data demonstrate that current guidelines for
the transport of specimens within 72 h are sufﬁcient to maintain
specimen integrity even at temperatures well above the recom-
mended 2–8 1C. While it is reassuring that poliovirus in stool
remains relatively stable at moderately elevated temperature,
transport at temperatures 425 1C, especially if delivery is delayed,
could impact sample integrity and virus isolation results.
Based on the decay curves, a stool specimen with an average
baseline poliovirus titer of 104.57 CCID50/g would arrive at the
laboratory after 72 h of travel at 27 1C with a titer of 104.4, or less
than a half-log titer loss from baseline due to time and tempera-
ture. When traveling at 31 1C, an average titer specimen would
arrive at the laboratory after 72 h with a titer of 104.2 CCID50/g. If
an average-titer specimen experienced temperatures of 35 1C for
the 72 h transport, the titer expected at the laboratory would be
103.9 CCID50/g.
Under moderate to extreme time and temperature conditions,
however, falsely negative laboratory results could occur. There was
no loss in titer after up to 20 days incubation at 25 1C and only
minimal loss of titer due to temperature exposure at 27 1C for up
to 14 days, indicating a reverse cold chain transit of up to two
weeks at or below 25 1C would lead to isolation of poliovirus by
the laboratory if it were present in the specimen in average titers.
If the initial titer of the specimen is low, the titer will reach
undetectable levels more quickly than an average-titer specimen.
When low-titer specimens (o103.80CCID50/g) were exposed to
31 1C and 35 1C, they became undetectable by cell culture in 2 to
4 days.
Assuring that current reverse cold chain guidelines are fol-
lowed provides the best means for maintaining conﬁdence in the
laboratory results; this includes specimen storage and transport
below 8 1C to the extent possible and, more importantly, a transit
time of r72 h from collection to the laboratory. Data to document
adherence to current guidelines is necessary for use by regional
certiﬁcation committees when deliberating a region or nation's
polio-free status. Given the public health importance of polio
eradication and ensuring polio-free status, a low-cost time and
temperature monitoring method may be important in some
settings to assure that the extremes of time or temperature during
transport are uncommon.
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